Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373308 · ClinicalTrials.gov registry record
Quality of Life Following Radical Prostatectomy
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 888
- Enrollment target
NCT00373308: Completed study, sponsored by Stanford University.
NCT00373308 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 888 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00373308 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 888 participants
- Enrollment target
Study Summary
This study will utilize the Expanded Prostate Cancer Index Composite questionnaire to learn what impact the surgery has upon the participant's sense of health, sexual and urinary quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 888 participants |
| Start Date | 2002-09 |
| Est. Completion | 2020-12-25 |
What the finished NCT00373308 record still lists
NCT00373308 is an observational study that tracks outcomes without assigning an intervention. The registered 888 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00373308 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00373308 about?
NCT00373308 is a clinical study titled "Quality of Life Following Radical Prostatectomy". This study will utilize the Expanded Prostate Cancer Index Composite questionnaire to learn what impact the surgery has upon the participant's sense of health, sexual and urinary quality of life.
What is the current status of trial NCT00373308?
This trial is currently completed. The enrollment target is 888 participants. The study started on 2002-09. Estimated completion is 2020-12-25.
Who is sponsoring clinical trial NCT00373308?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03564340 · 890 participants · Phase 1
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT07196748 · 882 participants · Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- NCT04862663 · 895 participants · Phase 3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia